Albumin Fusion Proteins

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8946156
SERIAL NO

13464248

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acid vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • HUMAN GENOME SCIENCES, INC.;NOVOZYMES BIOPHARMA DK A/S

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ballance, David J Berwyn, US 32 1175
Prior, Christopher P Rosemont, US 37 989
Sadeghi, Homayoun Doylestown, US 44 759
Sleep, Darrell West Bridgford, GB 81 972
Turner, Andrew J King of Prussia, US 37 1170

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 3, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00